Korea), equipped with a TC-C18 column (4.6 mm, 250 mm, and 5 μm,
Agilent, USA), in conjunction with a gradient system composed of solvent
A (0.2% formic acid) and solvent B (MeOH). The slope solvent ratio
was set to 0–5 min, 15% B; 5–10 min, 15–20% B;
10–15 min, 20–30% B; 15–30 min, 30–40%
B; 30–37 min, 40–60% B; 37–40 min, 60–100%
B; 40–45 min, 100% B; 45–50 min, 100–15% B; and
50–55 min, 15% B. To identify the ingredients in solvent fractions,
the mobile phase was delivered at a flow rate of 1 mL/min, and the
detection of elute was carried out at 330 nm. To collect the bioactive
ingredients in solvent fractions, the mobile phase was delivered at
a flow rate of 15.0 mL/min, and the detection of elute was carried
out at 330 nm using prep-HPLC (YL-9100 s, Young Lin Instrument, Korea),
equipped with a prep-C18 column (4.6 mm, 212 mm, 10 μm, Agilent,
USA), in conjunction with a gradient system composed of solvent A
(0.2% formic acid) and solvent B (MeOH). The slope solvent ratio was
set to 0–10 min, 10% B; 10–20 min, 10–15% B;
20–40 min, 15% B; 40–60 min, 15–20% B; and 60–70
min, 30% B.